Nerve conduction study (NCS) findings play a well-validated role in diagnosing demyelinating polyneuropathies. Common features in demyelinating polyneuropathies include slowed conduction velocity, ...

Multiple sclerosis (MS) is an immune-mediated inflammatory demyelinating disease of the central nervous system (CNS) with a variety of clinical presentations and unclear pathogenesis. More than 2.8 ...

Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare, acquired neurological disorder with heterogeneous presentation. It is a peripheral nerve system immune-mediated condition which ...

Sanofi is halting the phase 3 MOBILIZE trial evaluating riliprubart for chronic inflammatory demyelinating polyneuropathy due to lack of efficacy.

The growth of the chronic inflammatory demyelinating polyneuropathy market is expected to be primarily driven by an expanding ...